Chapter 1. Vaccine Contract Manufacturing Market– Scope & Methodology
1.1    Market Segmentation
1.2    Assumptions
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
Chapter 2. Vaccine Contract Manufacturing Market– Executive Summary
2.1    Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
2.3    COVID-19 Impact Analysis
        2.3.1    Impact during 2023 – 2030
       2.3.2    Impact on Supply – Demand
Chapter 3. Vaccine Contract Manufacturing Market– Competition Scenario
3.1    Market Share Analysis
3.2    Product Benchmarking
3.3    Competitive Strategy & Development Scenario
3.4    Competitive Pricing Analysis
3.5    Supplier - Distributor Analysis
Chapter 4. Vaccine Contract Manufacturing Market- Entry Scenario
4.1     Case Studies – Start-up/Thriving Companies
4.2     Regulatory Scenario - By Region
4.3    Customer Analysis
4.4     Porter's Five Force Model
       4.4.1     Bargaining Power of Suppliers
       4.4.2     Bargaining Powers of Customers
       4.4.3    Threat of New Entrants
       4.4.4    .Rivalry among Existing Players
       4.4.5    Threat of Substitutes
Chapter 5. Vaccine Contract Manufacturing Market- Landscape
5.1     Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Vaccine Contract Manufacturing Market- By Vaccine Type
6.1    Inactivated Vaccines
6.2    Live-attenuated Vaccines
6.3    RNA Vaccines
6.4    Subunit Vaccines
6.5    Toxoid-based Vaccines
Chapter 7. Vaccine Contract Manufacturing Market- By Process
7.1    Downstream
       7.1.1    Analytical and QC Studies
       7.1.2    Fill and Finish
       7.1.3    Packaging
       7.1.4    Other Downstream Processes
7.2    Upstream
       7.2.1    Bacterial Expression Systems
       7.2.2    Baculovirus/Insect Expression Systems
       7.2.3    Mammalian Expression Systems
       7.2.4    Yeast Expression Systems
       7.2.5    Other Upstream Processes
Chapter 8. Vaccine Contract Manufacturing Market - By Scale of Operations
8.1    Preclinical
8.2    Clinical
8.3    Commercial
Chapter 9. Vaccine Contract Manufacturing Market- By End Use
9.1    Human Use
9.2    Veterinary 
Chapter 10. Vaccine Contract Manufacturing Market– By Region
10.1    North America
10.2    Europe
10.3    Asia-Pacific
10.4    Latin America
10.5    The Middle East
10.6    Africa
Chapter 11. Vaccine Contract Manufacturing Market– Company Profiles – (Overview, Product Portfolio, Financials, Developments)
11.1    Company 1
11.2    Company 2
11.3    Company 3
11.4    Company 4
11.5    Company 5
11.6    Company 6
11.7    Company 7
11.8    Company 8
11.9    Company 9
11.10    Company 10
 

Download Sample